Company performance
Current Price
as of Jan 17, 2025$10.99
P/E Ratio
N/A
Market Cap
$1.68B
Loading...
Description
Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.
Metrics
Overview
- HQSingapore, CE
- SectorHealth Technology
- IndustryBiotechnology
- TickerWVE
- Price$10.99-2.83%
Trading Information
- Market cap$1.68B
- Float77.10%
- Average Daily Volume (1m)851,043
- Average Daily Volume (3m)1,130,299
- EPS-$1.11
Company
- Revenue$53.61M
- Rev growth (1yr)-115.60%
- Net income-$61.78M
- Gross marginN/A
- EBITDA marginN/A
- EBITDA-$61.76M
- EV$811.12M
- EV/Revenue15.13
- P/EN/A
- P/S27.18
- P/B11.51
Documents
SEC Filings
Earnings Calls
Factset Street Account